tiprankstipranks
Facephi Biometria SA (ES:FACE)
BME:FACE

Facephi Biometria SA (FACE) AI Stock Analysis

Compare
11 Followers

Top Page

ES:FACE

Facephi Biometria SA

(BME:FACE)

Select Model
Select Model
Select Model
Rating:46Neutral
Price Target:
€2.50
▼(-1.19% Downside)
Action:ReiteratedDate:11/08/25
The overall stock score of 46 for ES:FACE reflects significant challenges, primarily driven by weak financial performance with declining revenue, deepening losses, and liquidity risks. Technical analysis suggests a neutral stance with no strong momentum, while valuation is unattractive due to negative earnings and lack of dividends. Financial performance, with the highest weight, is the most impactful factor in this assessment.
Positive Factors
Market Position
Facephi's leadership in biometric solutions positions it well in the growing security and fintech sectors, supporting long-term growth.
Negative Factors
Negative Profitability
Ongoing losses and negative profitability hinder the company's ability to reinvest and grow, posing a risk to long-term sustainability.
Read all positive and negative factors
Positive Factors
Negative Factors
Market Position
Facephi's leadership in biometric solutions positions it well in the growing security and fintech sectors, supporting long-term growth.
Read all positive factors

Facephi Biometria SA (FACE) vs. iShares MSCI Spain ETF (EWP)

Facephi Biometria SA Business Overview & Revenue Model

Company Description
Facephi Biometria, S.A. provides biometric facial recognition technology solutions primarily for banking sector in Latin America, the United States, Asia, and internationally. Its products include Facephi Beyond Biometrics, a multi-biometric solut...
How the Company Makes Money
Facephi Biometria SA generates revenue through multiple channels, primarily by offering its biometric software solutions on a subscription basis. The company charges clients for licensing its technology, which can include one-time fees as well as ...

Facephi Biometria SA Financial Statement Overview

Summary
Facephi Biometria SA's financial performance is weak for 2024. Revenue declined by 1.5%, gross profit margin dropped sharply to 45.7%, and net losses deepened with a net profit margin of -30.8%. The balance sheet shows asset growth but a high debt-to-equity ratio of 0.53 and negative ROE of -46.3%. Cash flow remains concerning with negative free cash flow of -4.53M, indicating liquidity risks. The score reflects significant operational and financial challenges.
Income Statement
25
Negative
Balance Sheet
40
Negative
Cash Flow
30
Negative
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue29.80M28.88M29.32M22.28M13.16M7.27M
Gross Profit14.85M13.21M25.90M22.92M13.46M6.97M
EBITDA2.05M-220.15K-4.77M3.30M821.13K-1.03M
Net Income-7.86M-8.88M-4.31M1.11M-553.90K-1.85M
Balance Sheet
Total Assets39.51M49.71M45.71M32.25M18.36M15.97M
Cash, Cash Equivalents and Short-Term Investments876.59K5.70M2.90M2.05M1.39M6.50M
Total Debt9.09M10.18M12.96M7.83M6.22M7.04M
Total Liabilities22.91M30.52M25.67M17.04M9.65M8.95M
Stockholders Equity16.60M19.19M20.04M15.21M8.71M7.02M
Cash Flow
Free Cash Flow-838.83K-4.53M-664.63K-7.88M-6.15M-860.99K
Operating Cash Flow4.50M724.43K853.21K-5.82M-3.60M1.43M
Investing Cash Flow-6.12M-5.28M-9.83M-2.20M-2.14M-2.66M
Financing Cash Flow384.38K7.56M9.54M8.60M1.30M6.63M

Facephi Biometria SA Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2.53
Price Trends
50DMA
2.35
Negative
100DMA
2.44
Negative
200DMA
2.51
Negative
Market Momentum
MACD
-0.05
Positive
RSI
41.91
Neutral
STOCH
25.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ES:FACE, the sentiment is Negative. The current price of 2.53 is above the 20-day moving average (MA) of 2.26, above the 50-day MA of 2.35, and above the 200-day MA of 2.51, indicating a bearish trend. The MACD of -0.05 indicates Positive momentum. The RSI at 41.91 is Neutral, neither overbought nor oversold. The STOCH value of 25.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ES:FACE.

Facephi Biometria SA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
60
Neutral
€327.71M26.626.22%18.40%18.62%
46
Neutral
€58.19M-3.4414.80%-56.85%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ES:FACE
Facephi Biometria SA
2.20
-0.20
-8.33%
ES:480S
Soluciones Cuatroochenta SA
14.10
-0.60
-4.08%
ES:AGIL
Agile Content SA
2.06
-0.64
-23.70%
ES:IZER
Izertis SA
9.38
0.12
1.30%
ES:SNG
Singular People SA
2.04
0.31
17.92%
ES:SCO
Seresco SA
5.90
0.34
6.12%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 08, 2025